Showing results (1541-1550 of 1,620) with videos related to

Sort By:
Pageof 162
Journal of Virology|May 29, 2015
Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2Ruchi M Newman, Susanna L Lamers, Brian Weiner, et al.
The Journal of Infectious Diseases|May 7, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV InfectionLesia K Dropulic, Makinna C Oestreich, Harlan L Pietz, et al.
Journal of the American College of Cardiology|December 1, 2022
Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art ReviewJeremy P Moore, Ariane Marelli, Luke J Burchill, et al.
Immunity|April 14, 2019
Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial CellsWei Bu, M Gordon Joyce, Hanh Nguyen, et al.
Cancer|March 24, 2017
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)Kevin Kalinsky, Sandra Lee, Krista M Rubin, et al.
The Journal of Infectious Diseases|March 15, 2021
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 VaccineKening Wang, Lesia Dropulic, Joel Bozekowski, et al.
Journal of the American College of Surgeons|November 24, 2007
Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studiesJ Pieter Noordzij, Stephanie L Lee, Victor J Bernet, et al.
Cell|August 18, 2015
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteMasaru Kanekiyo, Wei Bu, M Gordon Joyce, et al.
The Western Journal of Emergency Medicine|November 1, 2017
Characteristics of Emergency Medicine Residency Programs in ColombiaAndrés Patiño, Victor Alcalde, Camilo Gutierrez, et al.
The Journal of Infectious Diseases|May 10, 2020
Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 PathwaysMatthew K Howe, Kennichi Dowdell, Hye Sun Kuehn, et al.
Pageof 162